Sec61 Blockade by Mycolactone Inhibits Antigen Cross-Presentation
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Accurate Annotation of Human Protein-Coding Small Open Reading Frames
HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Nat Chem Manuscript Author Biol. Author Manuscript Author manuscript; available in PMC 2020 June 09. Published in final edited form as: Nat Chem Biol. 2020 April ; 16(4): 458–468. doi:10.1038/s41589-019-0425-0. Accurate annotation of human protein-coding small open reading frames Thomas F. Martinez1,*, Qian Chu1, Cynthia Donaldson1, Dan Tan1, Maxim N. Shokhirev2, Alan Saghatelian1,* 1Clayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, La Jolla, California 92037, USA 2Razavi Newman Integrative Genomics Bioinformatics Core, Salk Institute for Biological Studies, La Jolla, California 92037, USA Abstract Functional protein-coding small open reading frames (smORFs) are emerging as an important class of genes. However, the number of translated smORFs in the human genome is unclear because proteogenomic methods are not sensitive enough, and, as we show, Ribo-Seq strategies require additional measures to ensure comprehensive and accurate smORF annotation. Here, we integrate de novo transcriptome assembly and Ribo-Seq into an improved workflow that overcomes obstacles with previous methods to more confidently annotate thousands of smORFs. Evolutionary conservation analyses suggest that hundreds of smORF-encoded microproteins are likely functional. Additionally, many smORFs are regulated during fundamental biological processes, such as cell stress. Peptides derived from smORFs are also detectable on human leukocyte antigen complexes, revealing smORFs as a source of antigens. Thus, by including additional validation into our smORF annotation workflow, we accurately identify thousands of unannotated translated smORFs that will provide a rich pool of unexplored, functional human genes. Annotation of open reading frames (ORFs) from genome sequencing was initially carried out by locating in-frame start (AUG) and stop codons1–3. -
A Clearer Picture of the ER Translocon Complex Max Gemmer and Friedrich Förster*
© 2020. Published by The Company of Biologists Ltd | Journal of Cell Science (2020) 133, jcs231340. doi:10.1242/jcs.231340 REVIEW A clearer picture of the ER translocon complex Max Gemmer and Friedrich Förster* ABSTRACT et al., 1986). SP-equivalent N-terminal transmembrane helices that The endoplasmic reticulum (ER) translocon complex is the main gate are not cleaved off can also target proteins to the ER through the into the secretory pathway, facilitating the translocation of nascent same mechanism. In this SRP-dependent co-translational ER- peptides into the ER lumen or their integration into the lipid membrane. targeting mode, ribosomes associate with the ER membrane via ER Protein biogenesis in the ER involves additional processes, many of translocon complexes. These membrane protein complexes them occurring co-translationally while the nascent protein resides at translocate nascent soluble proteins into the ER, integrate nascent the translocon complex, including recruitment of ER-targeted membrane proteins into the ER membrane, mediate protein folding ribosome–nascent-chain complexes, glycosylation, signal peptide and membrane protein topogenesis, and modify them chemically. In cleavage, membrane protein topogenesis and folding. To perform addition to co-translational protein import and translocation, distinct such varied functions on a broad range of substrates, the ER ER translocon complexes enable post-translational translocation and translocon complex has different accessory components that membrane integration. This post-translational pathway is widespread associate with it either stably or transiently. Here, we review recent in yeast (Panzner et al., 1995), whereas higher eukaryotes primarily structural and functional insights into this dynamically constituted use it for relatively short peptides (Schlenstedt and Zimmermann, central hub in the ER and its components. -
X-Ray Structure of a Protein-Conducting Channel
articles X-ray structure of a protein-conducting channel Bert van den Berg1*, William M. Clemons Jr1*, Ian Collinson2, Yorgo Modis3, Enno Hartmann4, Stephen C. Harrison3 & Tom A. Rapoport1 1Howard Hughes Medical Institute and Department of Cell Biology, Harvard Medical School, 240 Longwood Avenue, Boston, Massachusetts 02115, USA 2Max Planck Institute of Biophysics, Marie-Curie-Strasse 13-15, D-60439 Frankfurt am Main, Germany 3Howard Hughes Medical Institute, Children’s Hospital and Harvard Medical School, 320 Longwood Avenue, Boston, Massachusetts 02115, USA 4University Luebeck, Institute for Biology, Ratzeburger Allee 160, Luebeck, D-23538, Germany * These authors contributed equally to this work ........................................................................................................................................................................................................................... A conserved heterotrimeric membrane protein complex, the Sec61 or SecY complex, forms a protein-conducting channel, allowing polypeptides to be transferred across or integrated into membranes. We report the crystal structure of the complex from Methanococcus jannaschii at a resolution of 3.2 A˚ . The structure suggests that one copy of the heterotrimer serves as a functional translocation channel. The a-subunit has two linked halves, transmembrane segments 1–5 and 6–10, clamped together by the g-subunit. A cytoplasmic funnel leading into the channel is plugged by a short helix. Plug displacement can open the channel into an ‘hourglass’ with a ring of hydrophobic residues at its constriction. This ring may form a seal around the translocating polypeptide, hindering the permeation of other molecules. The structure also suggests mechanisms for signal-sequence recognition and for the lateral exit of transmembrane segments of nascent membrane proteins into lipid, and indicates binding sites for partners that provide the driving force for translocation. -
Identification of Differentially Expressed Genes in Human Bladder Cancer Through Genome-Wide Gene Expression Profiling
521-531 24/7/06 18:28 Page 521 ONCOLOGY REPORTS 16: 521-531, 2006 521 Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling KAZUMORI KAWAKAMI1,3, HIDEKI ENOKIDA1, TOKUSHI TACHIWADA1, TAKENARI GOTANDA1, KENGO TSUNEYOSHI1, HIROYUKI KUBO1, KENRYU NISHIYAMA1, MASAKI TAKIGUCHI2, MASAYUKI NAKAGAWA1 and NAOHIKO SEKI3 1Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8520; Departments of 2Biochemistry and Genetics, and 3Functional Genomics, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan Received February 15, 2006; Accepted April 27, 2006 Abstract. Large-scale gene expression profiling is an effective CKS2 gene not only as a potential biomarker for diagnosing, strategy for understanding the progression of bladder cancer but also for staging human BC. This is the first report (BC). The aim of this study was to identify genes that are demonstrating that CKS2 expression is strongly correlated expressed differently in the course of BC progression and to with the progression of human BC. establish new biomarkers for BC. Specimens from 21 patients with pathologically confirmed superficial (n=10) or Introduction invasive (n=11) BC and 4 normal bladder samples were studied; samples from 14 of the 21 BC samples were subjected Bladder cancer (BC) is among the 5 most common to microarray analysis. The validity of the microarray results malignancies worldwide, and the 2nd most common tumor of was verified by real-time RT-PCR. Of the 136 up-regulated the genitourinary tract and the 2nd most common cause of genes we detected, 21 were present in all 14 BCs examined death in patients with cancer of the urinary tract (1-7). -
A Scalable Strategy for High-Throughput GFP Tagging of PNAS PLUS Endogenous Human Proteins
A scalable strategy for high-throughput GFP tagging of PNAS PLUS endogenous human proteins Manuel D. Leonettia,b,1, Sayaka Sekinec,1, Daichi Kamiyamac,2, Jonathan S. Weissmana,b,2, and Bo Huangc,2 aDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94143; bHoward Hughes Medical Institute, University of California, San Francisco, CA 94143; and cDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94143 Contributed by Jonathan S. Weissman, April 28, 2016 (sent for review April 6, 2016; reviewed by Hazen P. Babcock and Pietro De Camilli) A central challenge of the postgenomic era is to comprehensively cost-effective manner; (ii) specificity, limiting tag insertion to the characterize the cellular role of the ∼20,000 proteins encoded in genomic target (ideally in a “scarless” manner that avoids insertion the human genome. To systematically study protein function in a of irrelevant DNA such as selection marker genes); (iii) versatility native cellular background, libraries of human cell lines expressing of the tag, preferably allowing both localization and proteomic proteins tagged with a functional sequence at their endogenous analyses; and (iv) selectability of knockin cells. Recently, a strategy loci would be very valuable. Here, using electroporation of Cas9 based on electroporation of Cas9/single-guide RNA (sgRNA) ri- nuclease/single-guide RNA ribonucleoproteins and taking advan- bonucleoprotein complexes (RNPs) has been reported that enables tage of a split-GFP system, we describe a scalable method for the both scalability and specificity (14,15).Inthisapproach,RNPsare robust, scarless, and specific tagging of endogenous human genes assembled in vitro from purified sgRNA and Cas9, both of which with GFP. -
A Multiplexed Single-Cell CRISPR Screening Platform Enables Systematic Dissection of the Unfolded Protein Response
A Multiplexed Single-Cell CRISPR Screening Platform Enables Systematic Dissection of the Unfolded Protein Response The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Adamson, Britt et al. “A Multiplexed Single-Cell CRISPR Screening Platform Enables Systematic Dissection of the Unfolded Protein Response.” Cell 167, 7 (December 2016): 1867–1882 © 2016 Elsevier Inc As Published http://dx.doi.org/10.1016/J.CELL.2016.11.048 Publisher Elsevier Version Author's final manuscript Citable link http://hdl.handle.net/1721.1/116762 Terms of Use Creative Commons Attribution-NonCommercial-NoDerivs License Detailed Terms http://creativecommons.org/licenses/by-nc-nd/4.0/ HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Cell. Author Manuscript Author manuscript; Manuscript Author available in PMC 2017 December 15. Published in final edited form as: Cell. 2016 December 15; 167(7): 1867–1882.e21. doi:10.1016/j.cell.2016.11.048. A multiplexed single-cell CRISPR screening platform enables systematic dissection of the unfolded protein response Britt Adamson1,2,3,4,*, Thomas M. Norman1,2,3,4,*, Marco Jost1,2,3,4,5, Min Y. Cho1,2,3,4, James K. Nuñez1,2,3,4, Yuwen Chen1,2,3,4, Jacqueline E. Villalta1,2,3,4, Luke A. Gilbert1,2,3,4, Max A. Horlbeck1,2,3,4, Marco Y. Hein1,2,3,4, Ryan A. Pak1,6, Andrew N. Gray5, Carol A. Gross5,7,8, Atray Dixit9,10, Oren Parnas10,11, Aviv Regev10,12, and Jonathan S. Weissman1,2,3,4,† 1Department of Cellular & Molecular Pharmacology, -
Active and Passive Displacement of Transmembrane Domains Both Occur During Opsin Biogenesis at the Sec61 Translocon
2826 Research Article Active and passive displacement of transmembrane domains both occur during opsin biogenesis at the Sec61 translocon Nurzian Ismail, Samuel G. Crawshaw and Stephen High* Faculty of Life Sciences, University of Manchester, The Michael Smith Building, Oxford Road, Manchester, M13 9PT, UK *Author for correspondence (e-mail: [email protected]) Accepted 13 April 2006 Journal of Cell Science 119, 2826-2836 Published by The Company of Biologists 2006 doi:10.1242/jcs.03018 Summary We used a site-specific crosslinking approach to study the that its lateral exit from the translocon is clearly dependent membrane integration of the polytopic protein opsin at the upon the synthesis of subsequent transmembrane domains. endoplasmic reticulum. We show that transmembrane By contrast, the lateral exit of the third transmembrane domain 1 occupies two distinct Sec61-based environments domain occurred independently of any such requirement. during its integration. However, transmembrane domains Thus, even within a single polypeptide chain, distinct 2 and 3 exit the Sec61 translocon more rapidly in a process transmembrane domains display different requirements that suggests a displacement model for their integration for their integration through the endoplasmic reticulum where the biosynthesis of one transmembrane domain translocon, and the displacement of one transmembrane would facilitate the exit of another. In order to investigate domain by another is not a global requirement for this hypothesis further, we studied the integration -
NRF1) Coordinates Changes in the Transcriptional and Chromatin Landscape Affecting Development and Progression of Invasive Breast Cancer
Florida International University FIU Digital Commons FIU Electronic Theses and Dissertations University Graduate School 11-7-2018 Decipher Mechanisms by which Nuclear Respiratory Factor One (NRF1) Coordinates Changes in the Transcriptional and Chromatin Landscape Affecting Development and Progression of Invasive Breast Cancer Jairo Ramos [email protected] Follow this and additional works at: https://digitalcommons.fiu.edu/etd Part of the Clinical Epidemiology Commons Recommended Citation Ramos, Jairo, "Decipher Mechanisms by which Nuclear Respiratory Factor One (NRF1) Coordinates Changes in the Transcriptional and Chromatin Landscape Affecting Development and Progression of Invasive Breast Cancer" (2018). FIU Electronic Theses and Dissertations. 3872. https://digitalcommons.fiu.edu/etd/3872 This work is brought to you for free and open access by the University Graduate School at FIU Digital Commons. It has been accepted for inclusion in FIU Electronic Theses and Dissertations by an authorized administrator of FIU Digital Commons. For more information, please contact [email protected]. FLORIDA INTERNATIONAL UNIVERSITY Miami, Florida DECIPHER MECHANISMS BY WHICH NUCLEAR RESPIRATORY FACTOR ONE (NRF1) COORDINATES CHANGES IN THE TRANSCRIPTIONAL AND CHROMATIN LANDSCAPE AFFECTING DEVELOPMENT AND PROGRESSION OF INVASIVE BREAST CANCER A dissertation submitted in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY in PUBLIC HEALTH by Jairo Ramos 2018 To: Dean Tomás R. Guilarte Robert Stempel College of Public Health and Social Work This dissertation, Written by Jairo Ramos, and entitled Decipher Mechanisms by Which Nuclear Respiratory Factor One (NRF1) Coordinates Changes in the Transcriptional and Chromatin Landscape Affecting Development and Progression of Invasive Breast Cancer, having been approved in respect to style and intellectual content, is referred to you for judgment. -
Novel SEC61G–EGFR Fusion Gene in Pediatric Ependymomas Discovered by Clonal Expansion of Stem Cells in Absence of Exogenous Mi
Cancer Tumor and Stem Cell Biology Research Novel SEC61G–EGFR Fusion Gene in Pediatric Ependymomas Discovered by Clonal Expansion of Stem Cells in Absence of Exogenous Mitogens Tiziana Servidei1, Daniela Meco1, Valentina Muto2, Alessandro Bruselles3, Andrea Ciolfi2, Nadia Trivieri4, Matteo Lucchini5, Roberta Morosetti6, Massimiliano Mirabella5, Maurizio Martini7, Massimo Caldarelli8, Anna Lasorella9, Marco Tartaglia2, and Riccardo Riccardi1 Abstract The basis for molecular and cellular heterogeneity in ependy- yielding products lacking the entire extracellular ligand-binding momas of the central nervous system is not understood. This domain of the receptor while retaining the transmembrane and study suggests a basis for this phenomenon in the selection for tyrosine kinase domains. EGFR TKI efficiently targeted DN566/ mitogen-independent (MI) stem-like cells with impaired prolif- DN599-mutant–mediated signaling and prolonged the survival of eration but increased intracranial tumorigenicity. MI ependy- mice bearing intracranial xenografts of MI cells harboring these moma cell lines created by selection for EGF/FGF2-independent mutations. RT-PCR sequencing of 16 childhood ependymoma proliferation exhibited constitutive activation of EGFR, AKT, and samples identified SEC61G–EGFR chimeric mRNAs in one STAT3 and sensitization to the antiproliferative effects of EGFR infratentorial ependymoma WHO III, arguing that this fusion tyrosine kinase inhibitors (TKI). One highly tumorigenic MI line occurs in a small proportion of these tumors. Our findings harbored membrane-bound, constitutively active, truncated demonstrate how in vitro culture selections applied to geneti- EGFR. Two EGFR mutants (DN566 and DN599) were identified cally heterogeneous tumors can help identify focal mutations as products of intrachromosomal rearrangements fusing the 30 that are potentially pharmaceutically actionable in rare cancers. -
Identification of SEC61G As a Novel Prognostic Marker for Predicting Survival… CLINICAL RESEARCH © Med Sci Monit, 2019; 25: 3624-3635
CLINICAL RESEARCH e-ISSN 1643-3750 © Med Sci Monit, 2019; 25: 3624-3635 DOI: 10.12659/MSM.916648 Received: 2019.03.31 Accepted: 2019.04.24 Identification of SEC61G as a Novel Prognostic Published: 2019.05.16 Marker for Predicting Survival and Response to Therapies in Patients with Glioblastoma Authors’ Contribution: CDEF 1 Bo Liu 1 Department of Neurosurgery, Xiangya Hospital, Central South University, Study Design A F 1 Jingping Liu Changsha, Hunan, P.R. China Data Collection B 2 Department of Neurosurgery, The Second People’s Hospital of Hunan Province, Statistical Analysis C BD 1 Yuxiang Liao The Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, Data Interpretation D F 1 Chen Jin P.R. China Manuscript Preparation E F 1 Zhiping Zhang 3 Department of Psychiatry, The Second People’s Hospital of Hunan Province, The Literature Search F Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, P.R. China Funds Collection G F 1 Jie Zhao 4 Department of Clinical Pharmacology, Xiangya Hospital, Central South University, E 2 Kun Liu Changsha, Hunan, P.R. China E 2 Hao Huang F 3 Hui Cao ACG 1,4 Quan Cheng Corresponding Author: Quan Cheng, e-mail: [email protected] Source of support: This work was supported by the National Natural Science Foundation of China (No. 81703622); China Postdoctoral Science Foundation (No. 2018M633002); and Hunan Provincial Natural Science Foundation of China (No. 2018JJ3838) Background: The survival and therapeutic outcome vary greatly among glioblastoma (GBM) patients. Treatment resistance, including resistance to temozolomide (TMZ) and radiotherapy, is a great obstacle for these therapies. -
Protein Folding and Quality Control in the ER
Downloaded from http://cshperspectives.cshlp.org/ on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press Protein Folding and Quality Control in the ER Kazutaka Araki and Kazuhiro Nagata Laboratory of Molecular and Cellular Biology, Faculty of Life Sciences, Kyoto Sangyo University, Kamigamo, Kita-ku, Kyoto 803-8555, Japan Correspondence: [email protected] The endoplasmic reticulum (ER) uses an elaborate surveillance system called the ER quality control (ERQC) system. The ERQC facilitates folding and modification of secretory and mem- brane proteins and eliminates terminally misfolded polypeptides through ER-associated degradation (ERAD) or autophagic degradation. This mechanism of ER protein surveillance is closely linked to redox and calcium homeostasis in the ER, whose balance is presumed to be regulated by a specific cellular compartment. The potential to modulate proteostasis and metabolism with chemical compounds or targeted siRNAs may offer an ideal option for the treatment of disease. he endoplasmic reticulum (ER) serves as a complex in the ER membrane (Johnson and Tprotein-folding factory where elaborate Van Waes 1999; Saraogi and Shan 2011). After quality and quantity control systems monitor arriving at the translocon, translation resumes an efficient and accurate production of secretory in a process called cotranslational translocation and membrane proteins, and constantly main- (Hegde and Kang 2008; Zimmermann et al. tain proper physiological homeostasis in the 2010). Numerous ER-resident chaperones and ER including redox state and calcium balance. enzymes aid in structural and conformational In this article, we present an overview the recent maturation necessary for proper protein fold- progress on the ER quality control system, ing, including signal-peptide cleavage, N-linked mainly focusing on the mammalian system. -
Full-Text.Pdf
Systematic Evaluation of Genes and Genetic Variants Associated with Type 1 Diabetes Susceptibility This information is current as Ramesh Ram, Munish Mehta, Quang T. Nguyen, Irma of September 23, 2021. Larma, Bernhard O. Boehm, Flemming Pociot, Patrick Concannon and Grant Morahan J Immunol 2016; 196:3043-3053; Prepublished online 24 February 2016; doi: 10.4049/jimmunol.1502056 Downloaded from http://www.jimmunol.org/content/196/7/3043 Supplementary http://www.jimmunol.org/content/suppl/2016/02/19/jimmunol.150205 Material 6.DCSupplemental http://www.jimmunol.org/ References This article cites 44 articles, 5 of which you can access for free at: http://www.jimmunol.org/content/196/7/3043.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 23, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Systematic Evaluation of Genes and Genetic Variants Associated with Type 1 Diabetes Susceptibility Ramesh Ram,*,† Munish Mehta,*,† Quang T.